- Posts by Kelsey J. McElveen
OfficerAs a member of the firm’s Intellectual Property Litigation group, Kelsey focuses her practice on patent litigation under the Hatch-Waxman Act. After nearly a decade of experience working on Abbreviated New Drug Application ...
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
- EventPreparing for Immigration Policy Changes and the H-1B Lottery Under the Second Trump Administration
- Legal UpdateThe Issue of Available Remedies Under the National Labor Relations Act May Be Headed to the Supreme Court
- Legal UpdateCorporate Transparency Act Reporting Requirements Re-Instated, Deadline Extended
- EventEnforceable Business Protection Agreements: Making Sure Your Restrictive Covenants Are Worth the Paper They’re Written On